Recently, astrocyte-elevated gene-1 (AEG-1) and
insulin-like growth factor 1 (IGF-1) have been involved in the regulation of multiple signaling pathways in
tumorigenesis. To date, the detailed mechanisms underlying IGF-1-AEG-1 pathway-induced proliferation and apoptosis in cardiac
myxoma (CM) was not reported. In the present study, we used immnohistochemistry, immunoblotting, and qRT-PCR to detect the expression profile of
IGF-1 and AEG-1 in 90 CM tissues, and then cultured CM cells were subjected to si-AEG-1, in vitro, and in vivo assays. Our findings showed that
IGF-1 and AEG-1 were obviously upregulated in CM tissues and markedly associated with
tumor size. When CM cells were treated with si-AEG-1, si-AEG-1 attenuated IGF-1-induced CM cell growth and enhanced cell apoptosis. Mechanically, we validated the expression of AEG-1, p-Erk1/2, and p-Akt increased in CM cells in response to
IGF-1 treatment in a time-dependent manner. However, si-AEG-1 affected the expression of these
proteins. Functionally, we found the knockdown of AEG-1-inhibited G1/S transition and
tumor formation of CM cells. In conclusion, AEG-1 regulates IGF-1-induced proliferation and apoptosis via Erk1/2 and Akt signaling in CM development, which suggests IGF-1-AEG-1 signaling could be recommended to be a useful target to exert anti-
tumor effects on CM.